$ECOR
electroCore, Inc.

2024 Q2 Form 10-Q Financial Statement

#000121390024040888 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $6.139M $5.443M
YoY Change 72.88% 95.79%
Cost Of Revenue $838.0K $888.0K
YoY Change 43.25% 93.89%
Gross Profit $5.301M $4.555M
YoY Change 78.73% 96.17%
Gross Profit Margin 86.35% 83.69%
Selling, General & Admin $7.257M $8.005M
YoY Change 6.74% 19.3%
% of Gross Profit 136.9% 175.74%
Research & Development $635.0K $399.0K
YoY Change -45.02% -77.94%
% of Gross Profit 11.98% 8.76%
Depreciation & Amortization $201.0K $206.0K
YoY Change -37.58% 68.85%
% of Gross Profit 3.79% 4.52%
Operating Expenses $7.892M $8.404M
YoY Change -0.78% -1.35%
Operating Profit -$2.591M -$3.849M
YoY Change -48.06% -37.89%
Interest Expense $55.00K $225.0K
YoY Change 2344.44% 10956.51%
% of Operating Profit
Other Income/Expense, Net -$64.00K $221.0K
YoY Change -175.29% 85.71%
Pretax Income -$2.655M -$3.628M
YoY Change -45.85% -40.31%
Income Tax -$122.0K
% Of Pretax Income
Net Earnings -$2.655M -$3.506M
YoY Change -45.85% -40.24%
Net Earnings / Revenue -43.25% -64.41%
Basic Earnings Per Share -$0.38 -$0.53
Diluted Earnings Per Share -$0.38 -$0.53
COMMON SHARES
Basic Shares Outstanding 6.006M shares 6.003M shares
Diluted Shares Outstanding 7.046M shares 6.617M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.23M $7.849M
YoY Change 68.56% -34.09%
Cash & Equivalents $10.30M $7.849M
Short-Term Investments $3.928M
Other Short-Term Assets $610.0K $879.0K
YoY Change 71.35% 13.42%
Inventory $2.581M $2.507M
Prepaid Expenses
Receivables $538.0K $475.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.96M $11.71M
YoY Change 57.48% -23.83%
LONG-TERM ASSETS
Property, Plant & Equipment $181.0K $192.0K
YoY Change 58.77% 464.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $440.0K $448.0K
YoY Change -46.28% -49.72%
Total Long-Term Assets $4.396M $2.180M
YoY Change 56.0% -25.5%
TOTAL ASSETS
Total Short-Term Assets $17.96M $11.71M
Total Long-Term Assets $4.396M $2.180M
Total Assets $22.36M $13.89M
YoY Change 57.19% -24.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.456M $2.322M
YoY Change -36.25% 16.04%
Accrued Expenses $5.454M $5.412M
YoY Change 29.55% 43.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.252M $7.827M
YoY Change 10.3% 33.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.631M $1.567M
YoY Change 522.81% 159.01%
Total Long-Term Liabilities $3.631M $1.567M
YoY Change 522.81% 159.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.252M $7.827M
Total Long-Term Liabilities $3.631M $1.567M
Total Liabilities $10.88M $9.394M
YoY Change 52.04% 45.58%
SHAREHOLDERS EQUITY
Retained Earnings -$171.4M -$168.7M
YoY Change 9.05% 10.82%
Common Stock $182.8M $173.2M
YoY Change 11.27% 5.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.47M $4.496M
YoY Change
Total Liabilities & Shareholders Equity $22.36M $13.89M
YoY Change 57.19% -24.1%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$2.655M -$3.506M
YoY Change -45.85% -40.24%
Depreciation, Depletion And Amortization $201.0K $206.0K
YoY Change -37.58% 68.85%
Cash From Operating Activities -$1.772M -$2.558M
YoY Change -46.5% -56.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$3.928M
YoY Change
Cash From Investing Activities -$3.928M
YoY Change 4216.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.120M
YoY Change
NET CHANGE
Cash From Operating Activities -1.772M -$2.558M
Cash From Investing Activities -3.928M
Cash From Financing Activities 8.120M
Net Change In Cash 2.420M -$2.482M
YoY Change -171.11% -57.24%
FREE CASH FLOW
Cash From Operating Activities -$1.772M -$2.558M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Liabilities
Liabilities
9394000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11847000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
537000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2507000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
399000 usd
CY2024Q1 us-gaap Assets
Assets
13890000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
5000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.46
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001560258
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-38538
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
electroCore, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454976
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Forge Way
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockaway
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07866
CY2024Q1 dei City Area Code
CityAreaCode
973
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
290-0097
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
ECOR
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6006064 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7849000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10331000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
475000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
717000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2160000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
629000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
836000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14294000 usd
CY2024Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
607000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
192000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1540000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
502000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
448000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
495000 usd
CY2023Q4 us-gaap Assets
Assets
16102000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2322000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2163000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5412000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5871000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
93000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
89000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7827000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8123000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1567000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8660000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6006064 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6006064 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6002628 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6002628 shares
CY2024Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
6000 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
6000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
173188000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172704000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168710000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165204000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4496000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
7442000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13890000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16102000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5443000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2780000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
888000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
458000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
4555000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2322000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1809000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8005000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6710000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
8404000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
8519000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3849000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6197000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
225000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
119000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
4000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
221000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
119000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3628000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6078000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-122000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3506000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6617000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6617000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4743000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4743000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3506000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
56000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
76000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3430000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5811000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
7442000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3506000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
76000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
484000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
572000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3506000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
484000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
572000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
122000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
75000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-242000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-188000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-113000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-207000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-303000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
159000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-128000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-459000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1072000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-17000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2558000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5860000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2482000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5804000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10581000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17962000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8099000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12158000 usd
CY2024Q1 ecor Right Of Use Asset And Lease Liability Incurred From Operating Leases Of Lessee
RightOfUseAssetAndLeaseLiabilityIncurredFromOperatingLeasesOfLessee
1055000 usd
CY2023Q1 ecor Right Of Use Asset And Lease Liability Incurred From Operating Leases Of Lessee
RightOfUseAssetAndLeaseLiabilityIncurredFromOperatingLeasesOfLessee
usd
CY2024Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
122000 usd
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
211000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2000 usd
CY2024Q1 ecor Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 subsidiary
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_Q9Y8OSSSWG00000000000000000000b"> <table cellpadding="0" cellspacing="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> <p style="margin: 10pt 0pt 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit; font-family: 'times new roman', times;"><span style="line-height: inherit; margin: 6pt 0in 0in; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include trade credits, rebates, co-payment assistance and sales returns, valuation of inventory, estimated useful life of licensed products, income taxes, stock compensation, and contingencies.   </span></span></p> </div> </div> </div>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7849000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8099000 usd
CY2024Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4200000 usd
CY2024Q1 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.712 pure
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5443000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2780000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5443000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2780000 usd
CY2024Q1 ecor Payment Term For Customers
PaymentTermForCustomers
P30D
CY2024Q1 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
1153000 usd
CY2023Q4 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
832000 usd
CY2024Q1 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
776000 usd
CY2023Q4 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
1538000 usd
CY2024Q1 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
578000 usd
CY2023Q4 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
397000 usd
CY2024Q1 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
2507000 usd
CY2023Q4 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
2767000 usd
CY2024Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
607000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2507000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2160000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
600000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
700000 usd
CY2023Q4 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
500000 usd
CY2023Q4 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
100000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
38000000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
38000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1540000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
502000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
93000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
89000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1567000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
537000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1660000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
626000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.135 pure
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2024Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
22557
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
209000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
369000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
368000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
376000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
391000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
5227000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6940000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4260000 usd
CY2024Q1 ecor Operating Lease Liabilities Including Lease Not Yet Commenced
OperatingLeaseLiabilitiesIncludingLeaseNotYetCommenced
2680000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
387000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
282000 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1362000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2352000 usd
CY2024Q1 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1101000 usd
CY2023Q4 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1041000 usd
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
62000 usd
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
247000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
307000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 ecor Share Based Compensation Arrangement By Share Based Payment Granted
ShareBasedCompensationArrangementByShareBasedPaymentGranted
usd
CY2024Q1 ecor Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
655000 usd
CY2023Q4 ecor Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
655000 usd
CY2024Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
958000 usd
CY2023Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
628000 usd
CY2024Q1 ecor Accrued Inventory Purchases Current
AccruedInventoryPurchasesCurrent
204000 usd
CY2023Q4 ecor Accrued Inventory Purchases Current
AccruedInventoryPurchasesCurrent
usd
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
350000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
272000 usd
CY2024Q1 us-gaap Deferred Income Current
DeferredIncomeCurrent
130000 usd
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
245000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
203000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
149000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5412000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5871000 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1950000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
599000 shares
CY2024Q1 us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
122000 usd
CY2023Q1 us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
211000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
516000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q1 ecor Share Based Compensation Arrangement By Share Based Payment Exercised
ShareBasedCompensationArrangementByShareBasedPaymentExercised
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000 shares
CY2024Q1 ecor Share Based Compensation Arrangement By Share Based Payment Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentCancelled
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
501000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.03
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
349000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
293000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
58.13
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
76000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
484000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
572000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2400000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.50 pure
CY2024Q1 ecor Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate Of Peer Entities
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRateOfPeerEntities
0.50 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.46
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020Q3 ecor Number Of Investors As Defendants
NumberOfInvestorsAsDefendants
2 investors
CY2023Q1 ecor Number Of Former Employees
NumberOfFormerEmployees
2 pure

Files In Submission

Name View Source Status
ecor-20240331_def.xml Edgar Link unprocessable
0001213900-24-040888-index-headers.html Edgar Link pending
0001213900-24-040888-index.html Edgar Link pending
0001213900-24-040888.txt Edgar Link pending
0001213900-24-040888-xbrl.zip Edgar Link pending
ecor-20240331.htm Edgar Link pending
ecor-20240331.xsd Edgar Link pending
ex101_1.htm Edgar Link pending
ex311_2.htm Edgar Link pending
ex312_3.htm Edgar Link pending
ex321_4.htm Edgar Link pending
ex322_5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
ecor-20240331_cal.xml Edgar Link unprocessable
ecor-20240331_lab.xml Edgar Link unprocessable
ecor-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ecor-20240331_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending